- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
According to our latest study, the global Ankle Joint Pain Injection market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Ankle Joint Pain Injection market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Ankle Joint Pain Injection market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Ankle Joint Pain Injection market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Ankle Joint Pain Injection market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Ankle Joint Pain Injection market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Ankle Joint Pain Injection
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Ankle Joint Pain Injection market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Chugai Pharmaceutical, Seikagaku Corporation, Teva Pharmaceutical Industries, Zimmer Biomet Holdings and Flexion Therapeutics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Ankle Joint Pain Injection market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Corticosteroid Injections
Hyaluronic Acid Injections
Platelet Rich Plasma Injections
Others
Market segment by Application
Hospital
Clinic
Others
Major players covered
Chugai Pharmaceutical
Seikagaku Corporation
Teva Pharmaceutical Industries
Zimmer Biomet Holdings
Flexion Therapeutics
Dr. Reddy's Laboratories
Anika Therapeutics
Sanofi S.A
Pfizer
Wright Medical Group N.V
Ferring Pharmaceuticals
Bioventus
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Ankle Joint Pain Injection product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Ankle Joint Pain Injection, with price, sales, revenue and global market share of Ankle Joint Pain Injection from 2018 to 2023.
Chapter 3, the Ankle Joint Pain Injection competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Ankle Joint Pain Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Ankle Joint Pain Injection market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Ankle Joint Pain Injection.
Chapter 14 and 15, to describe Ankle Joint Pain Injection sales channel, distributors, customers, research findings and conclusion.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Ankle Joint Pain Injection
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Ankle Joint Pain Injection Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Corticosteroid Injections
1.3.3 Hyaluronic Acid Injections
1.3.4 Platelet Rich Plasma Injections
1.3.5 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Ankle Joint Pain Injection Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Others
1.5 Global Ankle Joint Pain Injection Market Size & Forecast
1.5.1 Global Ankle Joint Pain Injection Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Ankle Joint Pain Injection Sales Quantity (2018-2029)
1.5.3 Global Ankle Joint Pain Injection Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Chugai Pharmaceutical
2.1.1 Chugai Pharmaceutical Details
2.1.2 Chugai Pharmaceutical Major Business
2.1.3 Chugai Pharmaceutical Ankle Joint Pain Injection Product and Services
2.1.4 Chugai Pharmaceutical Ankle Joint Pain Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Chugai Pharmaceutical Recent Developments/Updates
2.2 Seikagaku Corporation
2.2.1 Seikagaku Corporation Details
2.2.2 Seikagaku Corporation Major Business
2.2.3 Seikagaku Corporation Ankle Joint Pain Injection Product and Services
2.2.4 Seikagaku Corporation Ankle Joint Pain Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Seikagaku Corporation Recent Developments/Updates
2.3 Teva Pharmaceutical Industries
2.3.1 Teva Pharmaceutical Industries Details
2.3.2 Teva Pharmaceutical Industries Major Business
2.3.3 Teva Pharmaceutical Industries Ankle Joint Pain Injection Product and Services
2.3.4 Teva Pharmaceutical Industries Ankle Joint Pain Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Teva Pharmaceutical Industries Recent Developments/Updates
2.4 Zimmer Biomet Holdings
2.4.1 Zimmer Biomet Holdings Details
2.4.2 Zimmer Biomet Holdings Major Business
2.4.3 Zimmer Biomet Holdings Ankle Joint Pain Injection Product and Services
2.4.4 Zimmer Biomet Holdings Ankle Joint Pain Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Zimmer Biomet Holdings Recent Developments/Updates
2.5 Flexion Therapeutics
2.5.1 Flexion Therapeutics Details
2.5.2 Flexion Therapeutics Major Business
2.5.3 Flexion Therapeutics Ankle Joint Pain Injection Product and Services
2.5.4 Flexion Therapeutics Ankle Joint Pain Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Flexion Therapeutics Recent Developments/Updates
2.6 Dr. Reddy's Laboratories
2.6.1 Dr. Reddy's Laboratories Details
2.6.2 Dr. Reddy's Laboratories Major Business
2.6.3 Dr. Reddy's Laboratories Ankle Joint Pain Injection Product and Services
2.6.4 Dr. Reddy's Laboratories Ankle Joint Pain Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Dr. Reddy's Laboratories Recent Developments/Updates
2.7 Anika Therapeutics
2.7.1 Anika Therapeutics Details
2.7.2 Anika Therapeutics Major Business
2.7.3 Anika Therapeutics Ankle Joint Pain Injection Product and Services
2.7.4 Anika Therapeutics Ankle Joint Pain Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Anika Therapeutics Recent Developments/Updates
2.8 Sanofi S.A
2.8.1 Sanofi S.A Details
2.8.2 Sanofi S.A Major Business
2.8.3 Sanofi S.A Ankle Joint Pain Injection Product and Services
2.8.4 Sanofi S.A Ankle Joint Pain Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Sanofi S.A Recent Developments/Updates
2.9 Pfizer
2.9.1 Pfizer Details
2.9.2 Pfizer Major Business
2.9.3 Pfizer Ankle Joint Pain Injection Product and Services
2.9.4 Pfizer Ankle Joint Pain Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Pfizer Recent Developments/Updates
2.10 Wright Medical Group N.V
2.10.1 Wright Medical Group N.V Details
2.10.2 Wright Medical Group N.V Major Business
2.10.3 Wright Medical Group N.V Ankle Joint Pain Injection Product and Services
2.10.4 Wright Medical Group N.V Ankle Joint Pain Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Wright Medical Group N.V Recent Developments/Updates
2.11 Ferring Pharmaceuticals
2.11.1 Ferring Pharmaceuticals Details
2.11.2 Ferring Pharmaceuticals Major Business
2.11.3 Ferring Pharmaceuticals Ankle Joint Pain Injection Product and Services
2.11.4 Ferring Pharmaceuticals Ankle Joint Pain Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Ferring Pharmaceuticals Recent Developments/Updates
2.12 Bioventus
2.12.1 Bioventus Details
2.12.2 Bioventus Major Business
2.12.3 Bioventus Ankle Joint Pain Injection Product and Services
2.12.4 Bioventus Ankle Joint Pain Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Bioventus Recent Developments/Updates
3 Competitive Environment: Ankle Joint Pain Injection by Manufacturer
3.1 Global Ankle Joint Pain Injection Sales Quantity by Manufacturer (2018-2023)
3.2 Global Ankle Joint Pain Injection Revenue by Manufacturer (2018-2023)
3.3 Global Ankle Joint Pain Injection Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Ankle Joint Pain Injection by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Ankle Joint Pain Injection Manufacturer Market Share in 2022
3.4.2 Top 6 Ankle Joint Pain Injection Manufacturer Market Share in 2022
3.5 Ankle Joint Pain Injection Market: Overall Company Footprint Analysis
3.5.1 Ankle Joint Pain Injection Market: Region Footprint
3.5.2 Ankle Joint Pain Injection Market: Company Product Type Footprint
3.5.3 Ankle Joint Pain Injection Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Ankle Joint Pain Injection Market Size by Region
4.1.1 Global Ankle Joint Pain Injection Sales Quantity by Region (2018-2029)
4.1.2 Global Ankle Joint Pain Injection Consumption Value by Region (2018-2029)
4.1.3 Global Ankle Joint Pain Injection Average Price by Region (2018-2029)
4.2 North America Ankle Joint Pain Injection Consumption Value (2018-2029)
4.3 Europe Ankle Joint Pain Injection Consumption Value (2018-2029)
4.4 Asia-Pacific Ankle Joint Pain Injection Consumption Value (2018-2029)
4.5 South America Ankle Joint Pain Injection Consumption Value (2018-2029)
4.6 Middle East and Africa Ankle Joint Pain Injection Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Ankle Joint Pain Injection Sales Quantity by Type (2018-2029)
5.2 Global Ankle Joint Pain Injection Consumption Value by Type (2018-2029)
5.3 Global Ankle Joint Pain Injection Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Ankle Joint Pain Injection Sales Quantity by Application (2018-2029)
6.2 Global Ankle Joint Pain Injection Consumption Value by Application (2018-2029)
6.3 Global Ankle Joint Pain Injection Average Price by Application (2018-2029)
7 North America
7.1 North America Ankle Joint Pain Injection Sales Quantity by Type (2018-2029)
7.2 North America Ankle Joint Pain Injection Sales Quantity by Application (2018-2029)
7.3 North America Ankle Joint Pain Injection Market Size by Country
7.3.1 North America Ankle Joint Pain Injection Sales Quantity by Country (2018-2029)
7.3.2 North America Ankle Joint Pain Injection Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Ankle Joint Pain Injection Sales Quantity by Type (2018-2029)
8.2 Europe Ankle Joint Pain Injection Sales Quantity by Application (2018-2029)
8.3 Europe Ankle Joint Pain Injection Market Size by Country
8.3.1 Europe Ankle Joint Pain Injection Sales Quantity by Country (2018-2029)
8.3.2 Europe Ankle Joint Pain Injection Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Ankle Joint Pain Injection Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Ankle Joint Pain Injection Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Ankle Joint Pain Injection Market Size by Region
9.3.1 Asia-Pacific Ankle Joint Pain Injection Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Ankle Joint Pain Injection Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Ankle Joint Pain Injection Sales Quantity by Type (2018-2029)
10.2 South America Ankle Joint Pain Injection Sales Quantity by Application (2018-2029)
10.3 South America Ankle Joint Pain Injection Market Size by Country
10.3.1 South America Ankle Joint Pain Injection Sales Quantity by Country (2018-2029)
10.3.2 South America Ankle Joint Pain Injection Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Ankle Joint Pain Injection Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Ankle Joint Pain Injection Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Ankle Joint Pain Injection Market Size by Country
11.3.1 Middle East & Africa Ankle Joint Pain Injection Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Ankle Joint Pain Injection Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Ankle Joint Pain Injection Market Drivers
12.2 Ankle Joint Pain Injection Market Restraints
12.3 Ankle Joint Pain Injection Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Ankle Joint Pain Injection and Key Manufacturers
13.2 Manufacturing Costs Percentage of Ankle Joint Pain Injection
13.3 Ankle Joint Pain Injection Production Process
13.4 Ankle Joint Pain Injection Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Ankle Joint Pain Injection Typical Distributors
14.3 Ankle Joint Pain Injection Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Ankle Joint Pain Injection Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Ankle Joint Pain Injection Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Chugai Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 4. Chugai Pharmaceutical Major Business
Table 5. Chugai Pharmaceutical Ankle Joint Pain Injection Product and Services
Table 6. Chugai Pharmaceutical Ankle Joint Pain Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Chugai Pharmaceutical Recent Developments/Updates
Table 8. Seikagaku Corporation Basic Information, Manufacturing Base and Competitors
Table 9. Seikagaku Corporation Major Business
Table 10. Seikagaku Corporation Ankle Joint Pain Injection Product and Services
Table 11. Seikagaku Corporation Ankle Joint Pain Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Seikagaku Corporation Recent Developments/Updates
Table 13. Teva Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 14. Teva Pharmaceutical Industries Major Business
Table 15. Teva Pharmaceutical Industries Ankle Joint Pain Injection Product and Services
Table 16. Teva Pharmaceutical Industries Ankle Joint Pain Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Teva Pharmaceutical Industries Recent Developments/Updates
Table 18. Zimmer Biomet Holdings Basic Information, Manufacturing Base and Competitors
Table 19. Zimmer Biomet Holdings Major Business
Table 20. Zimmer Biomet Holdings Ankle Joint Pain Injection Product and Services
Table 21. Zimmer Biomet Holdings Ankle Joint Pain Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Zimmer Biomet Holdings Recent Developments/Updates
Table 23. Flexion Therapeutics Basic Information, Manufacturing Base and Competitors
Table 24. Flexion Therapeutics Major Business
Table 25. Flexion Therapeutics Ankle Joint Pain Injection Product and Services
Table 26. Flexion Therapeutics Ankle Joint Pain Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Flexion Therapeutics Recent Developments/Updates
Table 28. Dr. Reddy's Laboratories Basic Information, Manufacturing Base and Competitors
Table 29. Dr. Reddy's Laboratories Major Business
Table 30. Dr. Reddy's Laboratories Ankle Joint Pain Injection Product and Services
Table 31. Dr. Reddy's Laboratories Ankle Joint Pain Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Dr. Reddy's Laboratories Recent Developments/Updates
Table 33. Anika Therapeutics Basic Information, Manufacturing Base and Competitors
Table 34. Anika Therapeutics Major Business
Table 35. Anika Therapeutics Ankle Joint Pain Injection Product and Services
Table 36. Anika Therapeutics Ankle Joint Pain Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Anika Therapeutics Recent Developments/Updates
Table 38. Sanofi S.A Basic Information, Manufacturing Base and Competitors
Table 39. Sanofi S.A Major Business
Table 40. Sanofi S.A Ankle Joint Pain Injection Product and Services
Table 41. Sanofi S.A Ankle Joint Pain Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Sanofi S.A Recent Developments/Updates
Table 43. Pfizer Basic Information, Manufacturing Base and Competitors
Table 44. Pfizer Major Business
Table 45. Pfizer Ankle Joint Pain Injection Product and Services
Table 46. Pfizer Ankle Joint Pain Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Pfizer Recent Developments/Updates
Table 48. Wright Medical Group N.V Basic Information, Manufacturing Base and Competitors
Table 49. Wright Medical Group N.V Major Business
Table 50. Wright Medical Group N.V Ankle Joint Pain Injection Product and Services
Table 51. Wright Medical Group N.V Ankle Joint Pain Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Wright Medical Group N.V Recent Developments/Updates
Table 53. Ferring Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 54. Ferring Pharmaceuticals Major Business
Table 55. Ferring Pharmaceuticals Ankle Joint Pain Injection Product and Services
Table 56. Ferring Pharmaceuticals Ankle Joint Pain Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Ferring Pharmaceuticals Recent Developments/Updates
Table 58. Bioventus Basic Information, Manufacturing Base and Competitors
Table 59. Bioventus Major Business
Table 60. Bioventus Ankle Joint Pain Injection Product and Services
Table 61. Bioventus Ankle Joint Pain Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Bioventus Recent Developments/Updates
Table 63. Global Ankle Joint Pain Injection Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 64. Global Ankle Joint Pain Injection Revenue by Manufacturer (2018-2023) & (USD Million)
Table 65. Global Ankle Joint Pain Injection Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 66. Market Position of Manufacturers in Ankle Joint Pain Injection, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 67. Head Office and Ankle Joint Pain Injection Production Site of Key Manufacturer
Table 68. Ankle Joint Pain Injection Market: Company Product Type Footprint
Table 69. Ankle Joint Pain Injection Market: Company Product Application Footprint
Table 70. Ankle Joint Pain Injection New Market Entrants and Barriers to Market Entry
Table 71. Ankle Joint Pain Injection Mergers, Acquisition, Agreements, and Collaborations
Table 72. Global Ankle Joint Pain Injection Sales Quantity by Region (2018-2023) & (K Units)
Table 73. Global Ankle Joint Pain Injection Sales Quantity by Region (2024-2029) & (K Units)
Table 74. Global Ankle Joint Pain Injection Consumption Value by Region (2018-2023) & (USD Million)
Table 75. Global Ankle Joint Pain Injection Consumption Value by Region (2024-2029) & (USD Million)
Table 76. Global Ankle Joint Pain Injection Average Price by Region (2018-2023) & (US$/Unit)
Table 77. Global Ankle Joint Pain Injection Average Price by Region (2024-2029) & (US$/Unit)
Table 78. Global Ankle Joint Pain Injection Sales Quantity by Type (2018-2023) & (K Units)
Table 79. Global Ankle Joint Pain Injection Sales Quantity by Type (2024-2029) & (K Units)
Table 80. Global Ankle Joint Pain Injection Consumption Value by Type (2018-2023) & (USD Million)
Table 81. Global Ankle Joint Pain Injection Consumption Value by Type (2024-2029) & (USD Million)
Table 82. Global Ankle Joint Pain Injection Average Price by Type (2018-2023) & (US$/Unit)
Table 83. Global Ankle Joint Pain Injection Average Price by Type (2024-2029) & (US$/Unit)
Table 84. Global Ankle Joint Pain Injection Sales Quantity by Application (2018-2023) & (K Units)
Table 85. Global Ankle Joint Pain Injection Sales Quantity by Application (2024-2029) & (K Units)
Table 86. Global Ankle Joint Pain Injection Consumption Value by Application (2018-2023) & (USD Million)
Table 87. Global Ankle Joint Pain Injection Consumption Value by Application (2024-2029) & (USD Million)
Table 88. Global Ankle Joint Pain Injection Average Price by Application (2018-2023) & (US$/Unit)
Table 89. Global Ankle Joint Pain Injection Average Price by Application (2024-2029) & (US$/Unit)
Table 90. North America Ankle Joint Pain Injection Sales Quantity by Type (2018-2023) & (K Units)
Table 91. North America Ankle Joint Pain Injection Sales Quantity by Type (2024-2029) & (K Units)
Table 92. North America Ankle Joint Pain Injection Sales Quantity by Application (2018-2023) & (K Units)
Table 93. North America Ankle Joint Pain Injection Sales Quantity by Application (2024-2029) & (K Units)
Table 94. North America Ankle Joint Pain Injection Sales Quantity by Country (2018-2023) & (K Units)
Table 95. North America Ankle Joint Pain Injection Sales Quantity by Country (2024-2029) & (K Units)
Table 96. North America Ankle Joint Pain Injection Consumption Value by Country (2018-2023) & (USD Million)
Table 97. North America Ankle Joint Pain Injection Consumption Value by Country (2024-2029) & (USD Million)
Table 98. Europe Ankle Joint Pain Injection Sales Quantity by Type (2018-2023) & (K Units)
Table 99. Europe Ankle Joint Pain Injection Sales Quantity by Type (2024-2029) & (K Units)
Table 100. Europe Ankle Joint Pain Injection Sales Quantity by Application (2018-2023) & (K Units)
Table 101. Europe Ankle Joint Pain Injection Sales Quantity by Application (2024-2029) & (K Units)
Table 102. Europe Ankle Joint Pain Injection Sales Quantity by Country (2018-2023) & (K Units)
Table 103. Europe Ankle Joint Pain Injection Sales Quantity by Country (2024-2029) & (K Units)
Table 104. Europe Ankle Joint Pain Injection Consumption Value by Country (2018-2023) & (USD Million)
Table 105. Europe Ankle Joint Pain Injection Consumption Value by Country (2024-2029) & (USD Million)
Table 106. Asia-Pacific Ankle Joint Pain Injection Sales Quantity by Type (2018-2023) & (K Units)
Table 107. Asia-Pacific Ankle Joint Pain Injection Sales Quantity by Type (2024-2029) & (K Units)
Table 108. Asia-Pacific Ankle Joint Pain Injection Sales Quantity by Application (2018-2023) & (K Units)
Table 109. Asia-Pacific Ankle Joint Pain Injection Sales Quantity by Application (2024-2029) & (K Units)
Table 110. Asia-Pacific Ankle Joint Pain Injection Sales Quantity by Region (2018-2023) & (K Units)
Table 111. Asia-Pacific Ankle Joint Pain Injection Sales Quantity by Region (2024-2029) & (K Units)
Table 112. Asia-Pacific Ankle Joint Pain Injection Consumption Value by Region (2018-2023) & (USD Million)
Table 113. Asia-Pacific Ankle Joint Pain Injection Consumption Value by Region (2024-2029) & (USD Million)
Table 114. South America Ankle Joint Pain Injection Sales Quantity by Type (2018-2023) & (K Units)
Table 115. South America Ankle Joint Pain Injection Sales Quantity by Type (2024-2029) & (K Units)
Table 116. South America Ankle Joint Pain Injection Sales Quantity by Application (2018-2023) & (K Units)
Table 117. South America Ankle Joint Pain Injection Sales Quantity by Application (2024-2029) & (K Units)
Table 118. South America Ankle Joint Pain Injection Sales Quantity by Country (2018-2023) & (K Units)
Table 119. South America Ankle Joint Pain Injection Sales Quantity by Country (2024-2029) & (K Units)
Table 120. South America Ankle Joint Pain Injection Consumption Value by Country (2018-2023) & (USD Million)
Table 121. South America Ankle Joint Pain Injection Consumption Value by Country (2024-2029) & (USD Million)
Table 122. Middle East & Africa Ankle Joint Pain Injection Sales Quantity by Type (2018-2023) & (K Units)
Table 123. Middle East & Africa Ankle Joint Pain Injection Sales Quantity by Type (2024-2029) & (K Units)
Table 124. Middle East & Africa Ankle Joint Pain Injection Sales Quantity by Application (2018-2023) & (K Units)
Table 125. Middle East & Africa Ankle Joint Pain Injection Sales Quantity by Application (2024-2029) & (K Units)
Table 126. Middle East & Africa Ankle Joint Pain Injection Sales Quantity by Region (2018-2023) & (K Units)
Table 127. Middle East & Africa Ankle Joint Pain Injection Sales Quantity by Region (2024-2029) & (K Units)
Table 128. Middle East & Africa Ankle Joint Pain Injection Consumption Value by Region (2018-2023) & (USD Million)
Table 129. Middle East & Africa Ankle Joint Pain Injection Consumption Value by Region (2024-2029) & (USD Million)
Table 130. Ankle Joint Pain Injection Raw Material
Table 131. Key Manufacturers of Ankle Joint Pain Injection Raw Materials
Table 132. Ankle Joint Pain Injection Typical Distributors
Table 133. Ankle Joint Pain Injection Typical Customers
List of Figures
Figure 1. Ankle Joint Pain Injection Picture
Figure 2. Global Ankle Joint Pain Injection Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Ankle Joint Pain Injection Consumption Value Market Share by Type in 2022
Figure 4. Corticosteroid Injections Examples
Figure 5. Hyaluronic Acid Injections Examples
Figure 6. Platelet Rich Plasma Injections Examples
Figure 7. Others Examples
Figure 8. Global Ankle Joint Pain Injection Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 9. Global Ankle Joint Pain Injection Consumption Value Market Share by Application in 2022
Figure 10. Hospital Examples
Figure 11. Clinic Examples
Figure 12. Others Examples
Figure 13. Global Ankle Joint Pain Injection Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global Ankle Joint Pain Injection Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global Ankle Joint Pain Injection Sales Quantity (2018-2029) & (K Units)
Figure 16. Global Ankle Joint Pain Injection Average Price (2018-2029) & (US$/Unit)
Figure 17. Global Ankle Joint Pain Injection Sales Quantity Market Share by Manufacturer in 2022
Figure 18. Global Ankle Joint Pain Injection Consumption Value Market Share by Manufacturer in 2022
Figure 19. Producer Shipments of Ankle Joint Pain Injection by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 20. Top 3 Ankle Joint Pain Injection Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Top 6 Ankle Joint Pain Injection Manufacturer (Consumption Value) Market Share in 2022
Figure 22. Global Ankle Joint Pain Injection Sales Quantity Market Share by Region (2018-2029)
Figure 23. Global Ankle Joint Pain Injection Consumption Value Market Share by Region (2018-2029)
Figure 24. North America Ankle Joint Pain Injection Consumption Value (2018-2029) & (USD Million)
Figure 25. Europe Ankle Joint Pain Injection Consumption Value (2018-2029) & (USD Million)
Figure 26. Asia-Pacific Ankle Joint Pain Injection Consumption Value (2018-2029) & (USD Million)
Figure 27. South America Ankle Joint Pain Injection Consumption Value (2018-2029) & (USD Million)
Figure 28. Middle East & Africa Ankle Joint Pain Injection Consumption Value (2018-2029) & (USD Million)
Figure 29. Global Ankle Joint Pain Injection Sales Quantity Market Share by Type (2018-2029)
Figure 30. Global Ankle Joint Pain Injection Consumption Value Market Share by Type (2018-2029)
Figure 31. Global Ankle Joint Pain Injection Average Price by Type (2018-2029) & (US$/Unit)
Figure 32. Global Ankle Joint Pain Injection Sales Quantity Market Share by Application (2018-2029)
Figure 33. Global Ankle Joint Pain Injection Consumption Value Market Share by Application (2018-2029)
Figure 34. Global Ankle Joint Pain Injection Average Price by Application (2018-2029) & (US$/Unit)
Figure 35. North America Ankle Joint Pain Injection Sales Quantity Market Share by Type (2018-2029)
Figure 36. North America Ankle Joint Pain Injection Sales Quantity Market Share by Application (2018-2029)
Figure 37. North America Ankle Joint Pain Injection Sales Quantity Market Share by Country (2018-2029)
Figure 38. North America Ankle Joint Pain Injection Consumption Value Market Share by Country (2018-2029)
Figure 39. United States Ankle Joint Pain Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Canada Ankle Joint Pain Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Mexico Ankle Joint Pain Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Europe Ankle Joint Pain Injection Sales Quantity Market Share by Type (2018-2029)
Figure 43. Europe Ankle Joint Pain Injection Sales Quantity Market Share by Application (2018-2029)
Figure 44. Europe Ankle Joint Pain Injection Sales Quantity Market Share by Country (2018-2029)
Figure 45. Europe Ankle Joint Pain Injection Consumption Value Market Share by Country (2018-2029)
Figure 46. Germany Ankle Joint Pain Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. France Ankle Joint Pain Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. United Kingdom Ankle Joint Pain Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Russia Ankle Joint Pain Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Italy Ankle Joint Pain Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Asia-Pacific Ankle Joint Pain Injection Sales Quantity Market Share by Type (2018-2029)
Figure 52. Asia-Pacific Ankle Joint Pain Injection Sales Quantity Market Share by Application (2018-2029)
Figure 53. Asia-Pacific Ankle Joint Pain Injection Sales Quantity Market Share by Region (2018-2029)
Figure 54. Asia-Pacific Ankle Joint Pain Injection Consumption Value Market Share by Region (2018-2029)
Figure 55. China Ankle Joint Pain Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Japan Ankle Joint Pain Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Korea Ankle Joint Pain Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. India Ankle Joint Pain Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Southeast Asia Ankle Joint Pain Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Australia Ankle Joint Pain Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. South America Ankle Joint Pain Injection Sales Quantity Market Share by Type (2018-2029)
Figure 62. South America Ankle Joint Pain Injection Sales Quantity Market Share by Application (2018-2029)
Figure 63. South America Ankle Joint Pain Injection Sales Quantity Market Share by Country (2018-2029)
Figure 64. South America Ankle Joint Pain Injection Consumption Value Market Share by Country (2018-2029)
Figure 65. Brazil Ankle Joint Pain Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Argentina Ankle Joint Pain Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 67. Middle East & Africa Ankle Joint Pain Injection Sales Quantity Market Share by Type (2018-2029)
Figure 68. Middle East & Africa Ankle Joint Pain Injection Sales Quantity Market Share by Application (2018-2029)
Figure 69. Middle East & Africa Ankle Joint Pain Injection Sales Quantity Market Share by Region (2018-2029)
Figure 70. Middle East & Africa Ankle Joint Pain Injection Consumption Value Market Share by Region (2018-2029)
Figure 71. Turkey Ankle Joint Pain Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Egypt Ankle Joint Pain Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Saudi Arabia Ankle Joint Pain Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. South Africa Ankle Joint Pain Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. Ankle Joint Pain Injection Market Drivers
Figure 76. Ankle Joint Pain Injection Market Restraints
Figure 77. Ankle Joint Pain Injection Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of Ankle Joint Pain Injection in 2022
Figure 80. Manufacturing Process Analysis of Ankle Joint Pain Injection
Figure 81. Ankle Joint Pain Injection Industrial Chain
Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
